The Europe diagnostic testing market size is calculated at USD 60.31 billion in 2025 and is predicted to attain around USD 81.05 billion by 2035, expanding at a CAGR of 3.00% from 2026 to 2035. Due to the prevalence of lifestyle-related and infectious diseases, a growing elderly population and demand for faster diagnosis, advances in laboratory automation, precision medicine and government healthcare initiatives are also supporting market expansion across Europe.

Europe Diagnostic Testing Market Statical Scope

The European diagnostic testing market is witnessing rapid technological advancement driven by innovations in molecular diagnostics ; legislation sequencing and AI-based data interpretation automation in laboratories has improved accuracy and turnaround time, while point of clear and at-home testing solutions are expanding accessibility; integration of digital health platforms and cloud-based reporting systems is enhancing efficiency. Additionally, personalized medicine and biomarker-based testing are supportive of more precise disease detection and treatment of diseases across the region.

Europe Diagnostic Testing Market, By Type, 2025 (%)

• Clinical Diagnostic- The segment dominated the market with a 74.00% share, due to strong preventive healthcare programs, extensive laboratory networks, frequent blood testing, and high reliance on accurate hospital-based diagnostics.
• Home Diagnostic- The segment accounted for 26.00% of the total market share, Due to rising self-care awareness, demand for convenient testing, growing e-commerce access, and preference for private health monitoring solutions.

Europe Diagnostic Testing Market, By Approach, 2025 (%)

• Molecular Diagnostic Instrument - The segment accounted for 32.00% of the total market share, due to increasing demand for precise pathogen detection, genetic analysis, modern laboratory upgrades, and expanding use in personalized treatment planning.
• In-Vitro Diagnostic Instrument - The segment dominated the market with 46.00% share, due to broad use in hospitals, routine laboratory screening automated workflows, and strong demand for reliable high volume testing services.
• Point Of Care Testing Instrument - The segment accounted for 22.00% of the total market share, due to faster bedside results, growing urgent care demand, decentralized healthcare services, and access in remote areas.

Europe Diagnostic Testing Market, By Solution, 2025 (%)

• Services - The segment accounted for 42.00% of the total market share, due to rising outsourced laboratory testing, equipment maintenance needs, data management support, and specialized diagnostic consultation demand.
• Products - The segment dominated the market with a 58.00% share, due to steady demand for test kids test kits, reagents, analysers, and continuous replacement needs across laboratories and hospitals.

Europe Diagnostic Testing Market, By Mode of Testing, 2025 (%)

• Prescription Based Testing- The segment dominated the market with a 69.00% share, due to physician led care pathways, reimbursement linked referrals, strict clinical guidelines, and strong trust in supervised medical diagnostics.
• OTC Testing- The segment accounted for 31.00% of the total market share, because consumer increasingly preferred quick home checks, wider retail distribution, discreet testing methods, and better awareness of preventive care.

Europe Diagnostic Testing Market, By Age, 2025 (%)

• Adult & Geriatric - The segment dominated the market with a 72.00% share, because older population require frequent laboratory checks, preventive screenings, and continuous management of age-related health conditions.
• Paediatric -The segment accounted for 28.00% of the total market share, due to routine newborn screening, vaccination-related testing, infection diagnosis, and growing focus on early childhood health monitoring.

Europe Diagnostic Testing Market, By Distribution Channel, 2025 (%)

• Direct Tenders - The segment dominated the market with a 52.00% share, due to bulk purchasing by public hospitals, cost efficient contracts, transparent procurement systems, and stable long term supplier agreements.
• Retail Sales - The segment accounted for 28.00% of the total market share, because pharmacies and health store widely supply rapid test kits, supporting convenient purchases and growing preventive healthcare habits.
• Online Sales- The segment accounted for 20.00% of the total market share, because digital platforms may test kits easier to compare, order quickly, and receive strictly across urban and rural areas.

Top Companies in the Europe Diagnostic Testing Market

• F-Hoffman La-Rcohe Ltd. (Switzerland)
• Danaher (US)
• BD (US)
• Thermo Fisher Scientific Inc. (US)
• ACON Laboratories Inc. (US)
• Hemosure, Inc. (US)
• MicroGen Diagnostics (US)
• Grifols, S.A (Spain)
• BODITECH MED INC. (South Korea)
• Chembio Diagnostic Systems, Inc. (US)
• Nanoentek (South Korea)
• DiaSorin S.p.A. (Italy)
• Bio-Rad Laboratories, Inc. (US)
• BIOMEDOMICS INC (US)
• EKF Diagnostics Holdings plc (UK)
• Siemens Healthcare GmbH (Germany)
• PerkinElmer Inc. (US)
• bioMérieux SA (France)
• ARKRAY USA, Inc. (US)
• Biohit Oyj (Finland)
• Quidel Corporation (US)
• Illumina, Inc. (US)
• Lamdagen Corporation (US)
• LifeSign LLC. (US)
• Medixbiochemica (Finaland)
• Nova Biomedical (US)
• Ortho Clinical Diagnostics (US)
• Sannuo Biosensing Co., Ltd. (US)
• STRECK (US)
• Sysmex Corporation (Japan)

Segments Covered in the Report

By Type

Clinical Diagnostic
Home Diagnostic

By Approach

Molecular Diagnostic Instrument
In-Vitro Diagnostic Instrument
Point Of Care Testing Instrument

By Solution

• Services
• Products

By Mode of Testing

• Prescription Based Testing
• OTC Testing

By Age

• Adult & Geriatric
• Paediatric

By Distribution Channel

• Direct Tenders
• Retail Sales
• Online Sales